M09A Other drugs for disorders of the musculo-skeletal system
M09AA
Quinine
Quinine is a medication used to treat malaria and babesiosis. This includes the treatment of malaria due to ''Plasmodium falciparum'' that is resistant to chloroquine when artesunate is not available. While sometimes used for nocturnal leg cr ...
and derivatives
:M09AA01
Hydroquinine
:M09AA72 Quinine, combinations with psycholeptics
M09AB Enzymes
:M09AB01
Chymopapain
Chymopapain (, ''chymopapain A'', ''chymopapain B'', ''chymopapain S'', brand name Chymodiactin) is a proteolytic enzyme isolated from the latex of papaya (''Carica papaya''). It is a cysteine protease which belongs to the papain-like protease (PL ...
:M09AB02
Collagenase ''clostridium histolyticum''
:M09AB03
Bromelains
:M09AB52
Trypsin
Trypsin is an enzyme in the first section of the small intestine that starts the digestion of protein molecules by cutting these long chains of amino acids into smaller pieces. It is a serine protease from the PA clan superfamily, found in the dig ...
, combinations
M09AX Other drugs for disorders of the musculo-skeletal system
:M09AX01
Hyaluronic acid
Hyaluronic acid (; abbreviated HA; conjugate base hyaluronate), also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans ...
:M09AX02
Chondrocytes, autologous
:M09AX03
Ataluren
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics.
Medical use
Ataluren is used in the European Union to treat people with Duchenne muscular dys ...
:M09AX04
Drisapersen
:M09AX05
Aceneuramic acid
:M09AX06
Eteplirsen
Eteplirsen (brand name Exondys 51) is a medication to treat, but not cure, some types of Duchenne muscular dystrophy (DMD), caused by a specific mutation. Eteplirsen only targets specific mutations and can be used to treat about 14% of DMD cases. ...
:M09AX07
Nusinersen
:M09AX08
Golodirsen
:M09AX09
Onasemnogene abeparvovec
Onasemnogene abeparvovec, sold under the brand name Zolgensma, is a gene therapy medication used to treat spinal muscular atrophy (SMA). It is used as a one-time intravenous injection, infusion into a vein.
Onasemnogene abeparvovec works by p ...
:M09AX10
Risdiplam
:M09AX11
Palovarotene
:M09AX12
Viltolarsen
Viltolarsen, sold under the brand name Viltepso, is a medication used for the treatment of Duchenne muscular dystrophy (DMD). Viltolarsen is a Morpholino antisense oligonucleotide.
The most common side effects include upper respiratory tract inf ...
:M09AX13
Casimersen
:QM09AX90 Equine stem cells
:QM09AX99 Combinations
References
{{Other drugs for disorders of the musculo-skeletal system
M09